Background: Shigellosis is the leading cause of diarrheal deaths worldwide and is particularly dangerous in children under 5 years of age in low- and middle-income countries. Additionally, the rise in antibiotic resistance has highlighted the need for an effective vaccine. Previously, we have used the Multiple Antigen-Presenting System (MAPS) technology to generate monovalent and quadrivalent MAPS vaccines that induce functional antibodies against components.
Methods: In this work, we detail the development of several monovalent vaccines using O-specific polysaccharides (OSPs) from four dominant serotypes, 2a, 3a, and 6, and . We tested several rhizavidin (rhavi) fusion proteins and selected a -specific protein IpaB. Quadrivalent MAPS were made with Rhavi-IpaB protein and tested in rabbits for immunogenicity.
Results: Individual MAPS vaccines generated robust, functional antibody responses against both IpaB and the individual OSP component. Antibodies to IpaB were effective across serotypes. We also demonstrate that the OSP antibodies generated are specific to each homologous O type by performing ELISA and bactericidal assays. We combined the components of each MAPS vaccine to formulate a quadrivalent MAPS vaccine which elicited similar antibody and bactericidal responses compared to their monovalent counterparts. Finally, we show that the quadrivalent MAPS immune sera are functional against several clinical isolates of the serotypes used in the vaccine.
Conclusions: This quadrivalent MAPS vaccine is immunogenicity and warrants further study.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11510904 | PMC |
http://dx.doi.org/10.3390/vaccines12101091 | DOI Listing |
Vaccines (Basel)
September 2024
Division of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Background: Shigellosis is the leading cause of diarrheal deaths worldwide and is particularly dangerous in children under 5 years of age in low- and middle-income countries. Additionally, the rise in antibiotic resistance has highlighted the need for an effective vaccine. Previously, we have used the Multiple Antigen-Presenting System (MAPS) technology to generate monovalent and quadrivalent MAPS vaccines that induce functional antibodies against components.
View Article and Find Full Text PDFVaccines (Basel)
October 2023
Division of Infectious Diseases, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Bloodstream infections in low- and middle-income countries (LMICs) are most frequently attributed to invasive Salmonella disease caused by four primary serovars of enterica: Typhi, Paratyphi A, Typhimurium, and Enteritidis. We showed previously that a bivalent vaccine targeting . Typhi and .
View Article and Find Full Text PDFPLoS One
November 2021
Vaxxas Pty Ltd, Brisbane, Queensland, Australia.
Microarray patches (MAPs) have the potential to be a safer, more acceptable, easier to use and more cost-effective method for administration of vaccines when compared to the needle and syringe. Since MAPs deliver vaccine to the dermis and epidermis, a degree of local immune response at the site of application is expected. In a phase 1 clinical trial (ACTRN 12618000112268), the Vaxxas high-density MAP (HD-MAP) was used to deliver a monovalent, split inactivated influenza virus vaccine into the skin.
View Article and Find Full Text PDFOncol Lett
May 2021
Department of Gynecology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310002, P.R. China.
Determining the spatial distribution of human papillomavirus (HPV) and performing accurate public health analyses helps to distinguish areas of healthcare that require further research, and enables therapeutic techniques and approaches in healthcare to be focused more accurately. A total of 4,560 women were enrolled in the present study. Flow-through hybridization and gene chip assays were used to detect the genotypes of HPV infection.
View Article and Find Full Text PDFZhonghua Liu Xing Bing Xue Za Zhi
November 2020
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
To analyze the seasonality, age distribution of influenza B cases and matching degree of influenza B vaccine in China from 2011 to 2019, and provide evidences for the future surveillance, estimation of disease burden of influenza B, application of quadrivalent vaccines, and development of vaccine strategies. The epidemiological and virological surveillance data of influenza B from week 14 of 2011 to week 13 of 2019 obtained from National Influenza Surveillance Network were used to draw hot spot maps and conduct descriptive statistics to analyze the seasonality and age distribution of influenza B cases. The published antigenicity analysis results from the China Weekly Influenza Report were used to analyze the matching degree between the trivalent vaccine strain and the circulating influenza B strains.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!